Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingWages, Salaries and Other
Ratios

Marimed (MRMD) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Marimed (MRMD) over the last 13 years, with Q3 2025 value amounting to $108.0 million.

  • Marimed's Other Gross PP&E Adjustments rose 240.95% to $108.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.0 million, marking a year-over-year increase of 240.95%. This contributed to the annual value of $107.1 million for FY2024, which is 1355.1% up from last year.
  • Per Marimed's latest filing, its Other Gross PP&E Adjustments stood at $108.0 million for Q3 2025, which was up 240.95% from $106.3 million recorded in Q2 2025.
  • Marimed's 5-year Other Gross PP&E Adjustments high stood at $108.0 million for Q3 2025, and its period low was $42.5 million during Q1 2021.
  • Over the past 5 years, Marimed's median Other Gross PP&E Adjustments value was $79.3 million (recorded in 2023), while the average stood at $81.2 million.
  • In the last 5 years, Marimed's Other Gross PP&E Adjustments surged by 200.52% in 2021 and then skyrocketed by 5652.03% in 2022.
  • Quarter analysis of 5 years shows Marimed's Other Gross PP&E Adjustments stood at $53.5 million in 2021, then surged by 43.93% to $76.9 million in 2022, then grew by 22.58% to $94.3 million in 2023, then rose by 13.55% to $107.1 million in 2024, then grew by 0.82% to $108.0 million in 2025.
  • Its last three reported values are $108.0 million in Q3 2025, $106.3 million for Q2 2025, and $105.0 million during Q1 2025.